Sarco/endoplasmic reticulum Ca 2؉ -ATPases (SERCAs) pump Ca 2؉ into the endoplasmic reticulum. Recently, three human SERCA3 (h3a-c) proteins and a previously unknown rat SERCA3 (r3b/c) mRNA have been described. Here, we (i) document two novel human SERCA3 splice variants h3d and h3e, (ii) provide data for the expression and mechanisms regulating the expression of all known SERCA3 variants (r3a, r3b/c, and h3a-e), and (iii) show functional characteristics of the SERCA3 isoforms. h3d and h3e are issued from the insertion of an additional penultimate exon 22 resulting in different carboxyl termini for these variants. Distinct distribution patterns of the SERCA3 gene products were observed in a series of cell lines of hematopoietic, epithelial, embryonic origin, and several cancerous types, as well as in panels of rat and human tissues. Hypertension and protein kinase C, calcineurin, or retinoic acid receptor signaling pathways were found to differently control rat and human splice variant expression, respectively. Stable overexpression of each variant was performed in human embryonic kidney 293 cells, and the SERCA3 isoforms were fully characterized. All SERCA3 isoforms were found to pump Ca 2؉ with similar affinities. However, they modulated the cytosolic Ca 2؉ concentration ([Ca 2؉ ] c ) and the endoplasmic reticulum Ca 2؉ content ([Ca 2؉ ] er ) in different manners. A newly generated polyclonal antibody and a pan-SERCA3 antibody proved the endogenous expression of the three novel SERCA3 proteins, h3d, h3e, and r3b/c. All these data suggest that the SERCA3 gene products have a more widespread role in cellular Ca 2؉ signaling than previously appreciated.
The cytosolic free Ca 2ϩ concentration is a dynamic signal regulating a variety of important cellular functions such as secretion, contraction, metabolism, neuronal plasticity, and gene transcription (1) . The free Ca 2ϩ concentration is strictly controlled, in space, time, and amplitude. This very tight control is necessary to enable cells to extract relevant information from the Ca 2ϩ signal, but also implies that disturbances in the intracellular Ca 2ϩ signal can lead to a plethora of consequences.
Ca 2ϩ signaling is highly complex and comprises elementary and global oscillatory events involving endoplasmic reticulum (ER) 1 membrane proteins. Among the better known proteins are Ca 2ϩ channels, namely inositol 1,4,5-trisphosphate receptors (InsP 3 -Rs) (2) and Ca 2ϩ pumps or sarco/endoplasmic reticulum Ca 2ϩ -ATPases (SERCAs) (3) (4) (5) , which coordinate opposite Ca 2ϩ ion fluxes. InsP 3 -Rs induce peaks in cytosolic Ca 2ϩ concentration as a result of Ca 2ϩ release from ER, whereas SERCAs are involved in the falling phase of Ca 2ϩ transients because of Ca 2ϩ resequestration into the ER Ca 2ϩ stores. Although many data are available on the role of InsP 3 -Rs in Ca 2ϩ signaling, our knowledge of the role of SERCAs is more restricted. For 35 years research on these enzymes has focused on their biochemical and molecular characterization. The SERCA family includes three gene products, named SERCA1 (ATP2A1), -2 (ATP2A2), and -3 (ATP2A3), which give rise to alternatively spliced mRNA and protein isoforms. The SERCA1 and SERCA2 genes have been known for a while, and have two 3Ј end splice variants encoding different carboxyl termini isoforms, mainly expressed in adult (SERCA1a) and neonatal (SERCA1b) skeletal muscles, in cardiac muscle (SERCA2a), and in all cell types (SERCA2b). Intriguingly as regards the variety of non-muscle cell functions, compared with muscle cells, until 1998, a unique so-called non-muscle SERCA3a isoform was described (5) (6) (7) .
In recent years, there have been enormous advances in our understanding of SERCAs, including new insight into their structure (8) and their relevant physiological functions in human diseases (4, 9, 10) . SERCA1 gene mutations have been reported in some patients with Brody disease, a muscle disease. Various SERCA2 gene mutations have been reported in DarierWhite disease, a rare dermatosis characterized by focal areas of separation between keratinocytes (4). Missense mutations in * This work was supported in part by INSERM, the Association pour la Recherche sur le Cancer (France), and Hungarian Academy of Sciences Grant OTKA T032766. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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In the meanwhile, SERCA3 genes were suggested to possess a high degree of complexity. We and others showed that the human SERCA3 gene gives rise to two additional 3Ј end transcripts, SERCA3b and -3c (16 -18) , that we recently found to encode the predicted proteins in platelets and lymphoid Jurkat T cells (19) . Moreover, these splice products would present an uncommonly high degree of species specificity, as mice express slightly different SERCA3b and -3c mRNAs (20) from those of human origin, whereas rats are devoid of similar splice variants, but express a so-called SERCA3b/c mRNA (21) . Evidence for the existence of these mouse and rat SERCA3 proteins, however, is still lacking.
Here, we report (i) a growing family of SERCA3 isoforms, including the rat 3b/c and two novel human SERCA3d and SERCA3e proteins; (ii) their plural, diverse, and species-specific distribution patterns; (iii) factors involved in the regulation of their expressions; and (iv) their distinct functional properties determining both cytosolic and endoplasmic reticulum Ca 2ϩ concentrations. Taken together, these results should help the understanding of pathophysiological cell Ca 2ϩ signaling in a broad variety of cells.
EXPERIMENTAL PROCEDURES
Isolation of Human and Rat Platelets-Human blood was obtained from different healthy volunteers, and the investigation was performed according to the requirements of the Declaration of Helsinki. The isolation of human platelets was performed as previously described (22) . Sixteen-week-old WKY rats and SHR were supplied by the Centre d'É levage R. Janvier (Le Genest, France). Approximately 10 WKY rats and SHR were used. Animals were anesthetized with ether. Rat blood was diluted in 0.9% NaCl, and the isolation of rat platelets was performed as detailed in Ref. 21 . The isolation of rat tissues was as detailed in Ref. 21 .
Cell Culture-The megakaryocytic CHRF-288 11, MEG 01, and Dami as well as adrenal pheochromocytoma PC12 cells were generously given by Dr. Lieberman, Pr. J. Peries, and Pr. Treiman, respectively. The KATO III (gastric cancer), lymphoblastoid Jurkat-T (JurE6 -1 clone), promyelocytic HL-60, monocytic U937, HeLa (epithelial-like), NCI-H69 (lung cancer), and human embryonic kidney (HEK)-293 cell lines were obtained from the American Type Culture Collection (Rockville Pike, MD). All cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum and 2 mM L-glutamine. The PC12 cells were cultured as described in Ref. 23 .
Cell Treatments-Lymphocyte activation and induction of HL-60 cell differentiation were performed as previously described (24, 25) .
Preparations of Rat and Human Platelet, Recombinant HEK-293 Cell, and Rat Cerebellum Lysates and Membrane Proteins-Preparation of whole cell lysates from transfected HEK-293 cells (human recombinants) was as in Ref. 24 . Isolation of rat and human platelet and recombinant HEK-293 cell enriched intracellular membranes was as described in Refs. 21 and 22. For rat cerebellum membrane isolation, 20 mg of tissue was lysed by adding 1 ml of buffer containing 10 mM KCl, 20 mM Hepes (pH 7.4), 200 mM sucrose, 50 M EGTA, 50 M EDTA, 0.5 mM dithiothreitol, 0.2 unit/ml aprotinin, 50 M phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 50 g/ml soybean trypsin inhibitor, 40 g/ml Bowman-Birk trypsin-chymotrypsin inhibitor, and 5 g/ml pepstatin A. The lysate was centrifuged at 1200 ϫ g for 15 min at 4°C. The supernatant was centrifuged at 100,000 ϫ g for 1 h at 4°C. The pellet was resuspended in a buffer containing 160 mM KCl, 17 mM Hepes (pH 7.4), and 0.2 mM dithiothreitol; aliquoted; frozen; and kept at Ϫ80°C.
The protein concentration of the different lysates and membrane fractions was determined using bovine serum albumin as a standard.
Antibodies for Immunoblottings-For endogenous rat SERCA2b (r2b), and human SERCA2b (h2b), the pan-r and -h2b polyclonal antibody, anti-2b (21) , and pan-h2 monoclonal antibody, IID8 (22) , were used (BIOMOL, Plymouth Meeting, PA). For r3a and r3b/c transfectants, the pan-r and -h3 polyclonal antibody, the N89 (PA1-910, Affinity Bioreagents, Neshanic Station, NJ), directed against the extreme NH 2 -terminal part of the r3a protein (6, 7) and pan-SERCA polyclonal antibody, SERBIO (26), were used. For h3a-e transfectants, the N89 and a pan-h3, monoclonal antibody, PL/IM430, directed against the NH 2 -terminal part of SERCA3 proteins, as well as our recently developed isoform-specific (h3a, h3b, and h3c) polyclonal antibodies (19) , were used. For PMCAs and InsP 3 -Rs, the pan-PMCA monoclonal 5F10, the polyclonal anti-InsP 3 -RI (Affinity BioReagents), the polyclonal antiInsP 3 -RII (Santa Cruz Biotechnology, Santa Cruz, CA), and the monoclonal anti-InsP 3 -RIII (Transduction Laboratories, Lexington, KY) antibodies (22) were used. Secondary anti-rabbit, anti-guinea pig, and anti-mouse horseradish peroxidase-conjugated antibodies were from Jackson Immunoresearch (West Grove, PA). Antibody binding was detected using enhanced chemiluminescence Western blotting reagents according to the manufacturer's instructions (Amersham Biosciences, Little Chalfont, Bucks, UK). Luminograms were scanned using Adobe Photoshop and, where indicated, quantified by Molecular Analyst, version NIH Image 1. 62b7.
Generation and Characterization of a Novel Isoform (r3b/c)-specific Antibody-The antibody was generated by immunizing New Zealand rabbits with the bovine serum albumin-conjugated synthetic peptide (see Fig. 6A ) as described for isoform-specific anti-h3a and anti-h3c antibodies (19) . A portion of the antibody was purified from the final serum on peptide-Sepharose 4B affinity column. The sensitivity and the cross-reactivity of the antibody were analyzed by the Crosslink Laboratory (Budapest, Hungary) by performing both enzyme-linked immunosorbent assay and dot-blot experiments using the corresponding peptide-bovine serum albumin conjugate (data not shown).
Electrophoresis of Proteins and Western Blots-Electrophoresis was performed on 8% SDS-PAGE, and Western blots were treated as in Refs. 19, 21, and 22, for the N89, PL/IM430, 5F10, anti-InsP 3 -Rs, and anti-h3a-c antibodies. For the r3b/c protein, the nitrocellulose membranes were incubated with a 1:250 dilution of the anti-r3b/c antibody in Tris-buffered saline (pH 7.4), 0.1% Tween 20 for 4 h. After washing, the blots were treated with a 1:10,000 dilution of horseradish peroxidase-conjugated anti-rabbit IgG, for 1 h.
RNA Extraction and RT-PCR-Total RNA extraction from human and rat platelets, human cell lines, and rat tissues was as described (21, 22, 25) . For RT-PCR experiments, protocols essentially identical to those described in Refs. 21 and 22 were used. The primers used to amplify r2b and h2b, r3a, r3b/c, h3a, human SERCA3c (h3c), hPMCA1b, hPMCA4b, hInsP 3 -R types I, II, or III are detailed in Refs. 21 and 22. The primers used (Genosys Sigma-Aldrich, St. Louis, MO) to amplify human SERCA3b (h3b), SERCA3d (h3d) and SERCA3e (h3e) are in Table I . PCR was initiated by adding 1.25 units of Gold AmpliTaq DNA polymerase (Thermus aquaticus, PerkinElmer, Branchburg, NJ) and Touch Down-PCR was performed for 10 cycles with annealing temperature decrement from 65 to 55°C. PCR was conducted for different cycles, each consisting of successive periods of denaturation at 95°C for 1 min, annealing at 55°C (r2b and h2b), and 58 or 68°C (Fig.  4b ) for 1 min, and extension at 72°C for 1 min. GAPDH and r2b or h2b amplifications were used as internal RNA controls. PCR products were visualized on ethidium bromide-stained 1.5 and 2% agarose gels or by Southern blotting as in Ref. 22 . They were scanned using Adobe Photoshop and, where indicated, quantified by Molecular Analyst, version NIH Image 1.62b7.
Plasmid Constructions-For expression constructs, the cDNAs encoding the h2b in pcDNA3.1 (Pr. D. H. MacLennan), r3a in pBR322 (Dr. G. Shull), and the inactive h3a in pMT2 (Dr. J. Lytton) were used. The r3a cDNA was NotI/NheI-excised and subcloned in EcoRI-digested and dephosphorylated pcDNA3 mammalian expression vector (Invitrogen, Cergy Pontoise, France) (Dr. A. M. Lompré). 3Ј end r3b/c DNA was generated by PCR encompassing exons 17-21 (nucleotides 2605-3263). Products were SalI/BspMI-excised after oriented subcloning in pCR2.1 vector. The r3b/c complete cDNA was created by switching a SalI/ApaI fragment of r3a by the specific 3Ј end r3b/c product. The cDNA of the inactive h3a was EcoRI-excised and subcloned in pUC18. The active h3a was obtained by substituting a PCR-amplified 1149-bp BclI/EcoRV fragment where Ile 817 was replaced by Met. This cDNA was subcloned into EcoRI site of pcDNA3. 3Ј end variant-specific cDNAs were generated by overlap extension of two variant-specific PCR products covering the region encompassing exon 18 -23 (nucleotides 2674 -3290). Specific products were subcloned in pCR2.1, and then EcoRV/XbaI-excised after oriented subcloning in pUC18 vector. The h3a-e cDNAs were created by switching the EcoRV/XbaI fragment of the active h3a construct, by the 3Ј end variant-specific products. Each construct was verified by automated dye terminator sequencing (Applied Biosystems AB1 100 model 377, Genome Express, Grenoble, France) across the junctions and through the modified regions (data not shown).
Stable Transfections in HEK-293 Cells-cDNA for transfection was purified using the EndoFree plasmid kit (Qiagen, Hilden, Germany). Cells were plated at a density of ϳ1 ϫ 10 4 cells/cm 2 in 100-mm dishes. The following day, cells at ϳ60% confluence were transfected with 10 g of the different r3s and h3s and h2b cDNAs using the transfection agent ExGen 500 (Euromedex, Souffelweyersheim, France) according to the instructions of the manufacturer. In short, cell monolayers were exposed to DNA-polymer complexes in a small volume of serum-free RPMI 1640 in an incubator. After 1 h, serum-containing medium was carefully added to monolayers. To establish cell lines that stably express the different SERCA3 isoforms, the neomycin-resistant colonies were selected with 600 g/ml G418 (Invitrogen) in RPMI 1640. Approximately 2 weeks later, colonies were picked and grown as individual cell lines in the presence of 200 g/ml G418 for 2 weeks. A mean of 10 -12 neomycinresistant clones were screened for each SERCA transfection efficiencies by Western blotting (data not shown). A mean of three of the highest responsive clones was selected for characterization and Ca 2ϩ response studies.
Measurements of Ca 2ϩ Pumping Activity-Measurements of Ca 2ϩ pumping activity was essentially performed as described (27) . A cell sample of 0.4 ml was diluted into 1.6 ml of calcium-free, Hepes/KCl (pH 7.4) composed of 100 mM KCl, 100 mM sucrose, 20 mM Hepes, 1.4 mM MgCl 2 , 1.25 mM NaN 3 , 1 M Fluo-3, 5 g/ml oligomycin, and 37.5 g/ml saponin. After 5 min at 37°C, it was transferred to a constant temperature cuvette holder of a Shimadzu RF-1501 spectrofluorimeter (Shimadzu Europe, Duisburg, Germany). The free Ca 2ϩ level was adjusted by stepwise additions from a concentrated CaCl 2 solution, after which 2 mM ATP was added. Fluorescence intensities (F) were continuously recorded at 488-nm excitation and 526-nm emission wavelengths (slits of 10 nm). Calibrations were performed by addition of CaCl 2 or EGTA to obtain F max and F min values, respectively. Levels of [Ca 2ϩ ] were calculated from the binding equation ] er -Confluent HEK-293 cells were loaded with 1.75 M Fura-2-AM in culture medium for 45 min at 37°C, and then incubated with fresh medium for another 15 min. Cells were rinsed with phosphate-buffered saline, detached, collected by centrifugation, and washed twice in 5 ml of Hepes buffer (pH 7.45) containing 136 mM NaCl, 10 mM Hepes, 2.7 mM KCl, 2 mM MgCl 2 , 1 mg/ml D-glucose, and 1 mM CaCl 2 . Fluorescence measurements were performed with cuvets containing 2 ml of cell suspensions in Hepes buffer, using the same fluorimeter. For calculation of the [Ca 2ϩ ] c , the ratio of fluorescence at excitation wavelengths of 340 and 380 nm (emission at 510 nm) was calibrated according to Ref. 28 .
RESULTS

Alternative Splicing Generates Five Human SERCA3a-e mRNAs: Identification of Two Previously Unknown SERCA3d
and SERCA3e Species-The human and rat SERCA3 genes were recently found to give rise to distinct and species-specific 3Ј end splice variants, in addition to the h-and rSERCA3a mRNAs (h3a and r3a) (Fig. 1A) . The hSERCA3b (h3b) and hSERCA3c (h3c) mRNAs result from the partial or complete insertion of a penultimate exon 21. In rat platelets a rSERCA3b/3c (r3b/c) variant (GenBank accession no. AF458230) is present, in which the 5Ј-part of exon 21 lacks an ACLYP sequence (black box) and its 3Ј-part is extended (red box) and terminated using a novel stop codon Sb/c (21) . A search for similar 3b/c splice variant in human platelets (Fig.  1B) , performing RT-PCR, with sets of primers located in exons 18 -22, was unsuccessful. However, additional longer PCR products were detected either on agarose gels (Fig. 1B, I, 7 ) or by Southern blotting (Fig. 1B, II, 7 ) when we used primers P3 and P6 amplifying exons 21 and 22. These data pointed to the insertion of a novel exon into the intronic sequence linking exons 21 and 22. Searching for this novel exon, we PCR-amplified and sequenced (data not shown) two products of 144 and 157 bp (Fig. 1B, III, 8) .
We analyzed the genomic sequence of the 3Ј end of hSERCA3 gene (EMBL accession no. Y3021426) (Fig. 1C) , as well. We found a 58-bp exon, 188 bp from the beginning of the last intron, presenting canonical exon/intron boundary sites. This optional new exon 22 contains an internal 5Ј donor splice site (designated D 3 ). Its complete insertion in h3b and h3c mRNAs gives rise to two novel splice variants, termed hSERCA3d (h3d) (GenBank accession no. AF458228) and hSERCA3e (h3e) (GenBank accession no. AF458229), respectively. An illustration of how these SERCA3 splice variants are generated is shown in the upper part of Fig. 1D .
To prove that the additional PCR products shown in Fig. 1B (II, 7 and III, 8) were relevant to these h3d and h3e mRNAs, we PCR-amplified 3Ј end SERCA3 products covering exons 18 -23 from human platelets (lower part of Fig. 1D ). This demonstrated that these mRNAs include exon 18 (lanes 1 and 2), exons 20 -22 (lanes 3 and 4), and exon 23 (lanes 5 and 6). Their identities were verified by sequencing (data not shown). Taken together, this splicing mechanism leads to two additional hSERCA3 proteins, which differ in their COOH termini. The h3b-specific (1043 aa) and h3c-specific (1029 aa) COOH termini comprising the last 50 and 36 aa are replaced by a tail of 51 and 59 aa in h3d (1044 aa) and h3e (1052 aa), respectively (sequences in Fig. 6A ).
Differential Distribution of Rat and Human SERCA3 Splice Variants-To address the question of the physiological significance of such a plurality of SERCA3 variants detected in platelets, their expression patterns were monitored in other rat and human cells and tissues (Fig. 2) . We explored the expression of r3b/c by specific RT-PCR (21) in a panel of WKY rat tissues previously shown to co-express r2b and r3a (5, 29, 31). PC12 cells were included because they express two SERCA3 proteins, the 97-kDa r3a and a second one of 115 kDa (23, 32) , the predicted molecular mass for r3b/c ( Fig. 2A) . rSERCA2b (r2b) and GAPDH were used as internal controls to evaluate our semiquantitative RT-PCR. Cerebellum, small and large intestine, pancreas, and spleen were found to co-express the r3b/c variant with r2b and r3a as well as PC12 cells, albeit at very different levels, the highest being found in cerebellum (389 Ϯ 11%), spleen (167.5 Ϯ 9.5%), and pancreas (118 Ϯ 6%) compared with platelets. For hSERCA3 mRNAs (Fig. 2, B-E) , the expression patterns of h3a-e mRNAs were examined by specific RT-PCR using hematopoietic (panels B and C) and non-muscle cell lines (panel D) as well as different tissues (panel E). Cells representing early (MEG 01) and late (CHRF-288 11) stages of megakaryocytic differentiation, Dami, U937, and HL-60 cells were compared with platelets (19) . Extension to non-muscle cells was performed using several cancerous cell lines (KATO III, HeLa, NCI-H69) and, furthermore, cell type of embryonic (HEK-293) and fetal origin. A widespread selection of commercial normal tissues was also tested. Again, the housekeeping hSERCA2b (h2b) and GAPDH were used as internal controls. As preliminary experiments showed large variations, cells and tissues expressing all h3a-e variants were used as references to choose variant-specific PCR experimental conditions. Hematopoietic cells were found to co-express the h3a-e variants to increasing degrees, based on the differentiation state of the cells and/or their lineages. This is clear when comparing MEG 01 cells, which express very low levels of h3a-e (7 Ϯ 4, 8 Ϯ 5, 3 Ϯ 2.5, 9 Ϯ 3, and 7 Ϯ 2%, respectively, versus Jur E6 -1 cells) with the more differentiated CHRF-288 11 or U937 and Jur E6 -1 cells, which co-express the five h3a-e mRNAs at rather high levels, as do mature platelets. However, differences exist as regard their relative expressions, as shown in Fig. 2C (inset) , which appear decremental from h3a to h3e in platelets, as well as in other hematopoietic cells (data not shown). SERCA3 gene expression is not restricted to hematopoietic cells, but was also found in other cell types. Different hSERCA3 splice variants were found to be co-expressed with h2b depending on the cell origin. Such a cell-specific distribution of h3a-e mRNAs is exemplified in: (i) KATO III (gastric carcinoma) and HeLa cells, which slightly express h3e (23 Ϯ 13% versus NCI-H69 lung cancer cells); (ii) HEK-293 cells, which slightly express h3d (28 Ϯ 6% versus NCI-H69 cells), and (iii) in fetal liver and NCI-H69 cells, which variably co-express the five h3a-e mRNAs (41 Ϯ 7, 67 Ϯ 7, 52 Ϯ 6, 59 Ϯ 17, and 84 Ϯ 19%, respectively, versus NCI-H69 cells). Study of h3a-e expression in different tissues showed also different patterns with striking variations, the highest expression level being found in pancreas (100%) and lung for h3a-c (66 Ϯ 10, 76 Ϯ 18, and 69 Ϯ 12%, respectively) and h3e (56 Ϯ 4%). In contrast, h3d was rather equally expressed (from 60 to 100%) in the different tissues including cardiac and skeletal muscles, an unexpected finding that points to a housekeeping nature of this new SERCA3 isoform.
Control of the Transcription and Alternative Splicing of the Rat and Human SERCA3 Genes-To look for mechanisms involved in these processes, we investigated both a pathological model and in vitro-induced differentiation and activation of several cell lines (Fig. 3) . All these models were previously studied for modulation of SERCA expression; however, no data have been available for the expression patterns of the SERCA3 splice variants in these models. Neither are data for mechanisms regulating the expression of the SERCA3 gene products known.
Hypertension (Fig. 3A) is an in vivo model accompanied with abnormal blood and vessel cell Ca 2ϩ signaling. mRNAs were isolated from the WKY rat and SHR tissues indicated, and the level of splice variant expressions was analyzed as in Fig. 2 . Although r3a was found differently up-regulated (ϫ 1.4 -2.1), a drastic down-regulation of r3b/c, was found in all the tissues except pancreas (not involved in hypertension), although to different degrees, the highest being found in cerebellum (ϫ 7.3). This suggests that as yet unidentified factors involved in hypertension can directly or indirectly regulate rSERCA3 gene alternative splicing in vivo and that this is manifest as a specific feature in adult animals.
To investigate whether known factors, acting at different levels of the cell to achieve a specific cell function, can modulate SERCA3 splice variants, we studied the in vitro myeloid differentiation of HL-60 cells (Fig. 3, B and C) . Treatment of these cells with PMA (panel B) induces their differentiation toward a monocyte/macrophage-like phenotype mediated by PKC activation, whereas ATRA (panel C) induces their terminal neutrophil granulocytic differentiation, mediated by nuclear factors. An opposite regulation of total h2 proteins was reported together with similar up-regulations of total h3 proteins (25) . h2b mRNA expression agreed with protein data. For h3 RNAs, lineage-dependent, temporal, and variant-specific up-regulations of their expressions were observed. PMA induced delayed (days 2-3) h3a-e up-regulations as compared with ATRA (day 1). In addition to these distinct timings, they presented monophasic and biphasic patterns, respectively. Moreover, these convergent up-regulations differ in extent according to the splice variants. h3b (ϫ 2.7) and h3c (ϫ 2.0) were mainly concerned in PMA treatment of HL-60 cells, which express exon 21 but not exon 22 whereas ATRA preferentially affected h3d (ϫ 1.4) and h3e (ϫ 1.6), these two expressing both exons 21 and 22. This suggests that factors using different routes act at the selection of splice sites.
To look for transcription factors underlying differences in the expression of the splice variants, the model of lymphocyte activation (Fig. 3D ) mimicked by the effect of a combination of PMA and ionomycin on Jurkat T cells was used. The resulting PKC activation and Ca 2ϩ mobilization led to activation of calcineurin, induced signal transduction to the nucleus by transcription factor NF-AT, and altered gene expression. A downregulation of total h3 proteins and an up-regulation of total h2 proteins were observed (24) . Here, working at RNA level, minor up-regulation of h2b was observed coupled to different downregulations of the h3a-e variants. Major down-modulations of the expression of h3a (86.5 Ϯ 8.0%), h3c (58.5 Ϯ 4.5%), and h3e (46.0 Ϯ 7.5%) were detected, whereas the expression of h3b and h3d did not change such a significantly. Considering that the differences between the structures of h3b and h3d and those of h3c and h3e concerned the partial or complete insertion of exon 21, respectively, this may underline the role of the calcineurinsignaling pathway in the regulation of the h3b/h3c alternative splice site.
Stable Expression of Recombinant Rat and Human SERCA3
Isoforms-To study the new isoforms, rSERCA3 (3a and 3b/c) and hSERCA3 (3a-e) cDNAs were constructed and stably expressed in HEK-293 cells. Although 10 -12 clones were obtained for r3a and h3a-e recombinant proteins, only one, r3b/c, was established, which turned to be unstable. Varying condi- tions for r3b/c did not result in more efficient transfection. No explanation is yet available for such a discrepancy between this recombinant and the others. Fig. 4 characterizes one clone of each SERCA3 stable transfectant at RNA (panels A and B) and protein levels (panels C and D). Moreover, because the overexpression of one type of Ca 2ϩ -ATPase has been reported to possibly influence the expression of the other structures involved in Ca 2ϩ signaling (33), the expression of h2b and ubiquitous PMCA isoforms, hPMCA1b and hPMCA4b, as well as that of the hInsP 3 -RI, II and III (22) were studied. In all cases, HEK-293 cells transfected with empty vector (pcDNA3) were used as controls.
RNA studies showed for rat transfectants (panel A) (i) no modulation of endogenous h2b, (ii) the expected increase in r3a and r3b/c, (iii) slight up-regulations of hPMCAs, and (iv) slight variations in the expression of major hInsP 3 -RI and minor hInsP 3 -RII and RIII. Analyses of human transfectants showed (panel B) (i) no modulation of h2b except for h3e where it appeared to be down-regulated, (ii) the expected significant and specific up-regulations of h3a-e; (iii) no regulation of hPMCA1b, but a slight down-regulation of hPMCA4b in h3c and h3e, and (iv) slight regulations of hInsP 3 -Rs.
Similarly, recombinants were studied for protein expressions by SDS-PAGE followed by Western blotting. In agreement with their predicted mass in kDa, resolution of r3 and h3 proteins by 8% SDS-PAGE permitted us to easily separate r3a (109.3) from r3b/c (116.4). For h3a-e, h3a (109.2) was separated from h3c (112.4), whereas h3b (113.9) co-migrated with h3d (114.1) and h3e (114.9) in our hands. For Western blotting, the same pan-SERCA3 antibodies (N89, SERBIO, PL/IM430) and rat and human platelet membranes were used to estimate transfection efficiencies. Isoform-specific h3a-c antibodies were used as further controls. Pan or subtype-specific antibodies were used for hPMCAs and hInsP 3 
-R proteins (panels C and D).
r3 (panel C) and h3 (panel D) recombinant proteins showed high transfection efficiencies compared with HEK-293 cells transfected with pcDNA3. The overexpression levels reached those of rat or human platelet membranes (100,000 ϫ g fractions), as judged by higher or similar recognitions by the pan-SERCA3 antibodies. We could estimate that the increase in SERCA3 expression in transfected HEK-293 cells was ϳ150 -200-fold over their endogenous level in HEK-293 cells and ϳ3-and 1.5-fold over the endogenous rat and platelet SERCA3a, respectively. As expected, h3a, h3b, and h3c were recognized by the isoform-specific anti-h3a-c antibodies (19) , respectively. The anti-h3a antibody also recognized h3e. The peptide initially used to generate the anti-h3a antibody was later found to present partial sequence homology with h3e (see Fig. 6A ). The electrophoretic migrations of the r3 and h3 recombinant proteins were in agreement with their predicted molecular weights, regardless of which antibody was used (NH 2 -terminalor COOH-terminal-specific). This ensured the intact nature of recombinant proteins. As concerns endogenous h2b; hPMCA1b and -4b; and hInsP 3 -RI, -RII, and -RIII proteins, the results supported the slight variations of mRNAs except for hInsP 3 -RIII in r3a and h3e, and hInsP 3 -Rs in h3c. The apparent lower expression levels in r3 and h3 recombinants (compared with HEK-293 cells transfected with pcDNA3) are because of the high levels of overexpressed proteins that account in estimation of total proteins loaded onto the gels. As concerns the exceptions of hInsP 3 -Rs, a possible explanation is their distinct membrane location and recovery in mixed membrane fractions.
Functional Characteristics of the New Rat and Human SERCA3 Recombinant Proteins in Cellular Ca
2ϩ Responses- (34, 35) . In our work on intact cells, the Ca 2ϩ pumping properties of the r3 and h3 recombinant proteins were studied, using two techniques (Fig. 5) . The first one involves saponin permeabilization of transfected HEK-293 cells in the presence of the non-cell permeant Ca 2ϩ indicator Fluo-3, followed by ATP addition, upon which ATP-dependent removal of Ca 2ϩ from the cytosolic compartment was monitored. This method eliminates PMCA activities and enables us to determine the specific extent and Ca 2ϩ dependence of SERCA activity. For r3 and h3 recombinants, two to three clones were studied including those characterized in Fig. 4 . Ca 2ϩ pumping activities were measured at free [Ca 2ϩ ] ranging from 500 to 2000 nM (Fig. 5A) . The apparent Ca 2ϩ affinities of the transfected proteins were estimated after extrapolation of the data to a free [Ca 2ϩ ] at which the Ca 2ϩ pumping activities are deduced to be zero. The values were corrected for background SERCA activity in HEK-293 cells transfected with pcDNA3 (88 Ϯ 13 nmol/mg of protein/min). All recombinant proteins were found to function as Ca 2ϩ pumps, exhibiting similar apparent affinities toward Ca 2ϩ of ϳ800 nM (Fig. 5B) . In addition, the data were used to estimate relative pumping activities at ϳ1100 nM free [Ca 2ϩ ] (Fig. 5C) , i.e. close to the theoretical affinity of rat and human SERCA3a protein deduced from Ca 2ϩ transport studies (18) . Recombinant proteins were found to possess different Ca 2ϩ pumping activities (Fig. 5C) , which vary from 49 Ϯ 21 to 136 Ϯ , and recombinants selected for their highest SERCA3 protein expressions (data not shown) have been characterized for r3 and h3 recombinants and endogenous h2b, hPMCAs, and hInsP 3 -Rs. A, RNA study of rat transfectants. RT-PCR (n ϭ 5) was performed using 250 ng of RNA and 18 (r3a, r3b/c, h2b, GAPDH), 22 (hPMCA1b), 23 (hInsP 3 -RI, II, III), and 24 (hPMCA4b) cycles. B, RNA study of human transfectants (n ϭ 3) by using 250 ng of RNA and 17 (h2b, h3a, GAPDH), 22 (hPMCA1b), 23 (h3b, h3c, hInsP 3 -Rs), 24 (hPMCA4b), and 25 (h3d, h3e) cycles. C, protein study of rat recombinants. Panel shows blots (n ϭ 3) of 30 g of rat platelet and recombinant membrane proteins (SERCAs), 5 g of rat platelet, and 10 g of recombinant membrane proteins (hPMCAs and hInsP 3 -Rs). D, protein study of human recombinants. Panel shows blots (n ϭ 5) of 30 g of human platelet membrane proteins (SERCAs, hPMCAs, and hInsP 3 -Rs), 10 g of human whole cell lysate proteins of human recombinants (SERCAs and hPMCAs), and 50 g of recombinant membrane proteins (hInsP 3 -Rs).
47 nmol/mg of protein/min, over that of pcDNA3. The highest and lowest activities were found for r3a and h3c, respectively, whereas h3a-h3b-h3d and h3e gave intermediate values.
Resting [Ca 2ϩ ] c (Fig. 5 , panels D (for typical results) and E) were found to vary from 35.8 Ϯ 6.0 nM to 82.6 Ϯ 6.7 nM, the highest [Ca 2ϩ ] c being obtained in h3c-and h3e-transfected cells. The [Ca 2ϩ ] c results from the combined activity of InsP 3 -Rs, PMCAs, and SERCAs (Fig. 4) . However, in our studies, high Ca 2ϩ pumping activities and low resting [Ca 2ϩ ] c were found to coincide, thereby suggesting that it is the SERCA activity that determines [Ca 2ϩ ] c and that the involvement of PMCA activity in the present situation is minimal.
The [Ca 2ϩ ] er (Fig. 5 , panels D (for typical trace) and F) of cells transfected with h3a, h3c, and h3e constructs were found to be similar or slightly lower than those for cells transfected by pcDNA3 (201 Ϯ 25 nM). This slight decrease in releasable [Ca 2ϩ ] er might be explained by the formation of SERCA dimers, thereby creating Ca 2ϩ channels as reported (34) . h3b-, h3d-, and r3a-transfected cells were found to present considerably higher ionomycin-induced Ca 2ϩ responses, reaching 358 Ϯ 21, 348 Ϯ 23, and 335 Ϯ 21 nM, respectively. Among the alternatives to explain these differences in the increase in [Ca 2ϩ ] er is the localization of these SERCA-proteins in ER regions exposed to local increased [Ca 2ϩ ] and/or their association with resident ER regulatory molecules, as has previously been shown for h2b (36, 37 Existence of the Endogenous r3b/c, h3d, and h3e Proteins-To prove the existence of native proteins, studies were performed on tissue or cell membrane proteins by Western blotting using different antibodies (Fig. 6 ). Fig. 6A shows the carboxyl termini of rat and human SERCA3 variants and the epitopes of the isoform-specific antibodies used. For the r3b/c protein (Fig. 6B) , we used the N89 and SERBIO antibodies and generated a novel isoform-specific anti-r3b/c antibody. WKY rat and SHR cerebellum was studied because of the expected high expression of r3b/c in WKY rats and its down-regulation in hypertension ( Fig. 2A) . Western blot was first performed to check the specificity of the anti-r3b/c antibody (upper left). When using lysates from r3a-transfected HEK-293 cells, no protein band was detected, whereas a positive signal was obtained with the N89 antibody. By testing membranes fractionated from WKY rat cerebellum, with the N89, SERBIO, and anti-r3b/c antibodies in the absence or in the presence of the peptide used for immunization (upper middle), we detected the r3b/c protein. r3a and r3b/c proteins appeared as two dissociated protein bands with the N89 and SERBIO antibodies. The r3b/c protein (1061 aa) migrated at the expected molecular weight, i.e. at a lower position than PMCAs and a higher position than r3a (999 aa) and r2b (1042 aa). It co-migrated exactly with the upper bands recognized by the N89 and SERBIO antibodies. The r3b/c was recognized by the anti-r3b/c antibody, and the signal was abolished in the presence of 10 M synthetic peptide used for immunization. This identity of the r3b/c protein was confirmed by comparing proteins isolated from WKY rat and SHR cerebellum (lower). As expected, in SHR membranes, r3a was upregulated as revealed by the N89 and SERBIO antibodies whereas the r3b/c protein was drastically down-regulated, as shown by the N89, SERBIO, and anti-r3b/c antibodies. r2b was not modulated (21) . For the detection of the h3d and h3e proteins (Fig. 6C) , we used the pan-anti-h3, PL/IM430 antibody. To look for cells expressing h3d and h3e proteins, we re-investigated HEK-293 cells. By modifying the conditions of PCR used in Fig. 4 (28  versus 18 cycles) , and studying h3a-e RNAs expression in untreated HEK-293 cells and HEK-293 cells transfected either with pcDNA3 or with r3a, we (i) detected h3a in all three HEK-293 cell lines; (ii) showed the absence of h3b and h3c; (iii) confirmed the expression of h3d both in untreated HEK-293 cells and HEK-293 cells transfected with r3a, and furthermore its drastic down-regulation in HEK-293 cells transfected with pcDNA3; and (iv) found a slight expression of h3e in all three models of HEK-293 cells (Fig. 6C, left panel) . The amounts of h3a, h3d, and h3e mRNAs, however, remained very low. To circumvent the problem of the predicted low expression level of proteins as well, we probed high amounts of HEK-293 cell membrane proteins.
Western blots (Fig. 6C, right panel) showed that two protein bands could be detected in untreated HEK-293 cells or in HEK-293 cells transfected with pcDNA3 or r3a, when using the PL/IM430 antibody. The positions of these two protein bands corresponded well to the molecular weights expected for h3a and h3d or h3e proteins and appeared to be similar to those of the h3a and h3e proteins, respectively (see transfectants, left panel). Similar relative amounts of h3a and h3d or h3e were observed in HEK-293 cells and the r3a-transfected ones (the apparent lower expressions in r3a transfectant being the result of the high level of overexpressed r3a protein, which accounts in calculating the quantity of total membrane proteins loaded onto the gel). As h3e mRNA is expressed at lower level than h3d mRNA, we concluded that the protein band at 114. transfected with pcDNA3, we suggest that the remaining faint protein band at ϳ114.1 kDa refers to h3e. To try to establish the presence of h3e, we used the anti-h3a antibody that recognizes the h3e recombinant protein (Fig. 4D) . However, no specific protein band could be detected with this antibody. It can confirm a very low expression of the h3e protein and/or the lack of sensitivity of this antibody under these conditions. Taken together, these data demonstrate and/or strongly suggest the endogenous expression of the three novel SERCA3 isoforms, r3b/c, h3d, and h3e. DISCUSSION Here, we report that alternative splicings of the recently described SERCA3 genes result in multiple and species-specific variants, presenting diverse co-expressions in a variety of rat and human cells and tissues. Their splicing pattern is modulated as exemplified upon hematopoietic differentiation and in hypertension and is affected by various signalization pathways. Recombinant SERCA3 proteins exhibit distinct calcium pumping properties and differently modulate both basal [Ca 2ϩ ] c and the [Ca 2ϩ ] er . Western blot analysis performed using newly generated isoform-specific polyclonal anti-SERCA3 and a pan-SERCA3 monoclonal antibody demonstrated the existence of endogenous SERCA3 proteins. Altogether, the data show that alternative splicings of the SERCA3 genes generate a plurality of functionally distinct calcium pump isoforms in a broad variety of cells.
Multiple and Species-specific Co-expression of SERCA3 Isoforms-The first five members of the SERCA family (1a, 1b, 2a, 2b, and 3a), described 10 -15 years ago, were found by using techniques such as cloning or ribonuclease protection assay. One can say that a dogma has been accepted in the literature, consisting of (i) the strict muscle-specific expression of the 1a, 1b, and 2a variants; (ii) the ubiquitous nature of 2b; and (iii) the non-muscle-specific expression of the 3a isoform. Because of the low apparent Ca 2ϩ affinity, its functional role in Ca 2ϩ signaling has been questioned. Furthermore, no species specificity of these five SERCA proteins has been reported. Approximately 10 years were needed to discover two additional SERCA3b and -3c mRNAs by performing cloning and RT-PCR, a fact that initiated the revision of SERCA pumps and resulted in the finding and characterization of new SERCA3 gene products. We demonstrated the existence of five additional SERCA3 proteins: h3b (19); h3c (19) ; and h3d, h3e, and r3b/c (present work) in several cell types and/or tissues. These findings double the known members of the SERCA family. In addition, the existence of two similar but distinct mouse 3b and 3c proteins are expected, as well. Such an increasing plurality of SERCA proteins may provide additional possibilities for various cell types to tightly regulate their elementary and/or global Ca 2ϩ signals. There is variable and modulated redundancy of SERCA3 isoform expressions, according to cell and tissue functions. This would sustain the idea that the ER must be viewed as a modulable cellular compartment depending upon the relative distribution of SERCAs, which permit the governing of cell-specific Ca 2ϩ signaling (38) . A complex species specificity of the expression of the SERCA3 isoforms is more and more evident, which resides both in the nature of the isoforms as mentioned above, and in their cell-or tissue-specific expression patterns. Rat and human platelets express two and five SERCA isoforms, respectively. Similar relative expressions of 3a and 3b variants are observed in human and mouse kidney (17, 20) . Different relative expressions of 3a isoforms are found in rat and human brain, compared with pancreas or lung (Ref. 21 and present work). This particularity of the SERCA3 family might suggest that one isoform can be involved in different pathophysiological processes according to the species. Although this might explain some differences in humans and mice, it also complicates the use of animal models in seeking to understand the biological role of the hSERCA3 isoforms.
Our present data document that at least one member of the SERCA3 family, h3d, is equally expressed in all the tissues examined, including cardiac and skeletal muscles, abolishing the idea of the non-muscle cell-specific expression of the SERCA3 gene products.
Control of SERCA3 Alternative Splicings-The expression of the SERCA3 variants can vary as a function of pathophysiological situations, as exemplified here upon hematopoietic cell differentiation and in hypertension. This manipulation of alternative splicing presents a unique way of regulating Ca 2ϩ signaling processes. Many pathways are expected to regulate SERCA3 expression when considering the multiple sites for transcription factors present in the 5Ј-untranslated promoter region of the human SERCA3 gene (17) . The present work points to some of them. Calcineurin is now attracting wide attention as a regulator of gene transcription involved in Tlymphocyte activation, morphogenesis of heart valves, or myocardial hypertrophy (39) , all processes involving SERCA modulation. Here, we observed that the calcineurin pathway regulates SERCA3 gene expression in a splice variant-specific manner. This adds SERCAs to the other membrane proteins involved in Ca 2ϩ signaling (40 -42) recently shown to be targets of calcineurin regulation of transcription.
PKC signaling is involved in a variety of cell functions. Previously, we found major rapid and sustained induction of h3b and transitory h3c expression upon PMA-induced megakaryocytopoiesis (22) . Here, we show that PKC-induced monocyte/macrophage differentiation is also accompanied by convergent transcriptional up-regulations of h3a-e, which mainly concern h3b and h3c, but they are sustained and delayed.
Retinoic acid receptors regulate specific genes coding for proteins involved in differentiation and/or growth arrest (43) . This signaling pathway is also of clinical importance because differentiation therapy using retinoids is a very successful method in the treatment of acute promyelocytic leukemia. Our previous in vitro observations of up-regulations of SERCA3 proteins during myeloid differentiation were also found in vivo upon differentiation-induction therapy in patients with acute promyelocytic leukemia (25) . ATRA-induced granulocytic differentiation may mainly involve up-regulations of h3d and h3e, according to our present data.
Taken together, this means that the expression of h3a-e variants can be tightly regulated by effectors using different routes and is manifest in a time-and species-dependent manner. This would allow fine and spatiotemporal variations in Ca 2ϩ signals, a possible dynamic change in response to specific functional requirements, to fulfill optimally the demands for the fine-tuning of the intracellular effects of Ca 2ϩ signaling.
SERCA3 Isoforms Modulate Ca
2ϩ Signaling in Intact CellsUntil recently, possibly because of the belief in their restricted and cell-specific expression, no major attention was paid to the role of SERCAs in Ca 2ϩ signaling, except for SERCA2a (44) . However, mathematical modeling of experimental data and studies using SERCA inhibitors show that ER Ca 2ϩ pumps are involved in modifying Ca 2ϩ transient profiles and oscillatory patterns (45) . Recently, a direct and substantial refilling of ER by SERCAs occurring continuously during agonist-induced signaling was demonstrated (46) . Overexpression of SERCA1 was found to cause an increase in the frequency of Ca 2ϩ waves (47) , and the temporal patterns of Ca 2ϩ signals have been found to depend critically on the SERCA2a and -2b isoforms (36 ] er is involved in fundamental biochemical processes such as the folding and processing of newly synthesized membranes and secretory proteins. Although, over the last decades, interest has been focused on disturbances of [Ca 2ϩ ] c , recently, the ER has attracted attention as a subcellular compartment in which [Ca 2ϩ ] disturbances may contribute to pathological processes culminating in neuronal injury (30) .
Because Ca 2ϩ signaling accompanies many cell functions, the challenge now is to understand it and the mechanisms involved in the decoding of oscillatory calcium signals. A plurality of Ca 2ϩ signaling may be expected to turn the activation of a tremendous variety of receptor-dependent transduction signaling into highly specific biological responses. Now, at a time that the field of subcellular Ca 2ϩ homeostasis is evolving rapidly, the present findings open up areas of investigation seeking to understand normal and abnormal cell Ca 2ϩ signaling.
